Cargando…
A Genetic Risk Score Is Associated with Weight Loss Following Roux-en Y Gastric Bypass Surgery
BACKGROUND: Currently, Roux-en Y gastric bypass (RYGB) is the most efficient therapy for severe obesity. Weight loss after surgery is, however, highly variable and genetically influenced. Genome-wide association studies have identified several single nucleotide polymorphisms (SNP) associated with bo...
Autores principales: | Bandstein, Marcus, Voisin, Sarah, Nilsson, Emil K., Schultes, Bernd, Ernst, Barbara, Thurnheer, Martin, Benedict, Christian, Mwinyi, Jessica, Schiöth, Helgi B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985537/ https://www.ncbi.nlm.nih.gov/pubmed/26832135 http://dx.doi.org/10.1007/s11695-016-2072-9 |
Ejemplares similares
-
The Role of FTO and Vitamin D for the Weight Loss Effect of Roux-en-Y Gastric Bypass Surgery in Obese Patients
por: Bandstein, Marcus, et al.
Publicado: (2015) -
A genetic variant in proximity to the gene LYPLAL1 is associated with lower hunger feelings and increased weight loss following Roux-en-Y gastric bypass surgery
por: Bandstein, Marcus, et al.
Publicado: (2016) -
Roux-En Y Gastric Bypass Surgery Induces Genome-Wide Promoter-Specific Changes in DNA Methylation in Whole Blood of Obese Patients
por: Nilsson, Emil K., et al.
Publicado: (2015) -
Longitudinal genome-wide methylation study of Roux-en-Y gastric bypass patients reveals novel CpG sites associated with essential hypertension
por: Boström, Adrian E., et al.
Publicado: (2016) -
Early Postoperative Weight Loss Predicts Weight Loss up to 5 Years After Roux-En-Y Gastric Bypass, Banded Roux-En-Y Gastric Bypass, and Sleeve Gastrectomy
por: Tettero, Onno M., et al.
Publicado: (2022)